C almodulin (CaM) is recognized as a key regulatory molecule for diverse biological functions, such as muscular contraction.
C almodulin (CaM) is recognized as a key regulatory molecule for diverse biological functions, such as muscular contraction. 1 In addition, a recent study demonstrated that CaM-dependent protein kinases, such as CaM-dependent protein kinase II, may regulate hypertension through the mechanisms including promotion of vascular smooth muscle hypertrophy. 2 In the previous study, we compared expression levels of several CaM-related proteins with almost unknown functions in vasculature. As a result, we demonstrated that protein expression of eukaryotic elongation factor 2 kinase (also known as CaM-dependent protein kinase III), histone deacetylase 4, and death associated protein kinase (DAPK) 3 increased in the mesenteric artery from spontaneously hypertensive rats (SHRs) compared with Wistar Kyoto rats (WKYs). 3 In the recent study, we also showed that histone deacetylase 4 promotes reactive oxygen species (ROS)-dependent vascular inflammation and mediates the development of hypertension in SHRs. 4 However, it remains to be clarified how DAPK3, might affect vascular patholophysiology and control the development of hypertension. The DAPK protein has been considered as a Ca 2+ /CaMregulated serine/threonine kinase that mainly mediates cell death. 5 The DAPK protein consists of multiple domains, including an N-terminal kinase domain (known as a Ca 2+ /CaM regulatory region), ankyrin repeats, a cytoskeleton binding region, and a C-terminal death domain. 6 Various stimulation-induced intracellular calcium spikes promote the CaM binding to the CaM regulatory region of DAPK, which in turn activates DAPK. 7 Five protein kinases, including DAPK1, DAPK2, DAPK3 (also known as Zipper-interacting protein kinase), DAPK-related apoptosis-inducing protein kinase 1, and DAPK-related apoptosis-inducing protein kinase 2, are known as DAPK family proteins. 8 DAPK1, DAPK2, and DAPK3 are all ubiquitously expressed in various tissues from mice and rats. 6 Recently, the functions of DAPK3 were gradually clarified. The mutation of DAPK3
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promoted increased cell survival, proliferation, and resistance to chemotherapy in cancer cells. 9 In addition, it was shown that DAPK3 phosphorylated myosin light chain kinase, which may lead to apoptotic membrane blebbing. 10, 11 Enhanced phosphorylation of myosin light chain by DAPK3 was shown to increase smooth muscle contractility and cell motility. 10 It was further reported that DAPK3 regulates inflammatory signalings, including ribosomal protein L13a, extracellular signal-regulated kinase, and interferon-γ-activated inhibitor of translation in macrophages. 12 Vascular inflammation is known to be an important process for the development of hypertension at an early stage. In addition, a critical role for inflammation induced by ROS has been suggested in hypertension. 13 However, it remains to be clarified how DAPK3 controls hypertensive vascular diseases via inflammation. We, therefore, examined whether DAPK3 affects vascular smooth muscle and endothelial inflammatory responses and the development of hypertension. Here, we for the first time demonstrate that DAPK3 mediates ROS-dependent vascular inflammation and perhaps the development of hypertension via propagating vascular hypercontractility and hypertrophy in SHRs.
Materials and Methods
The detailed methods are available in the online-only Data Supplement.
Results

Effect of DAPK3 Knockdown on Tumor Necrosis Factor-α-Induced Inflammatory Responses in Vascular Smooth Muscle Cells
We first examined whether DAPK3 mediates inflammatory responses in smooth muscle cells (SMCs). For this purpose, we used 2 kinds of small interfering RNA (siRNA) against the DAPK3 gene and explored their effects on tumor necrosis factor (TNF)-α-induced inflammatory responses. We confirmed that Fold change (relative to cont siRNA) Figure 1 . Knockdown of the death-associated protein kinase (DAPK) 3 gene by small interfering RNA (siRNA) in cultured vascular smooth muscle cells (SMCs; A). After SMCs were transfected with 2 kinds of DAPK3-specific siRNA (DAPK3 siRNA-1 and -2) or nonsilencing control siRNA (control siRNA; 40 nmol/L, 24 hours), total cell lysates were harvested. Expression of DAPK3 protein (n=4) was determined by Western blotting and shown as fold increase relative to control siRNA. Equal protein loading was confirmed using an α-actin antibody. **P<0.01 vs control siRNA. Effect of DAPK3 knockdown on tumor necrosis factor (TNF)-α-induced vascular cell adhesion molecule (VCAM)-1 expression (B). After SMCs were transfected with DAPK3 or control siRNA, they were treated with 10 ng/mL of TNF for 24 hours. Expression of VCAM-1 (n=3-5) was determined by Western blotting and shown as fold increase relative to control siRNA without TNF stimulation. Equal protein loading was confirmed using α-actin antibody. **P<0.01 vs control siRNA without TNF stimulation; #P<0.05 vs control siRNA+TNF. Effect of DAPK3 knockdown on monocyte (U937 cells) adhesion to SMCs (C). After SMCs were transfected with DAPK3 siRNA, TNF-α (10 ng/mL, 24 hours) was treated. After adding U937 cells for 1 hour to SMCs, nonadherent cells were removed, and the number of adhering U937 cells was randomly counted in 3 areas (×200 fields) and averaged (n=6). Scale bar, 50 μm. The number of U937 cells adhering to SMCs was shown as fold increase relative to control siRNA with TNF stimulation. **P<0.01 vs control siRNA+TNF.
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DAPK3 protein was significantly silenced by each of the siRNAs ( Figure 1A ). It was further confirmed that TNFinduced DAPK3 expression was also significantly inhibited by DAPK3 siRNA ( Figure S1 , available in the online-only Data Supplement). TNF (10 ng/mL, 24 hours)-induced vascular cell adhesion molecule (VCAM)-1 expression was significantly inhibited by each DAPK3 siRNA ( Figure 1B ). We next examined whether DAPK3 knockdown inhibits monocyte adhesion to SMCs. The DAPK3 siRNA significantly decreased the number of monocyte adhesions to SMCs ( Figure 1C ). To explore upstream mechanisms of inhibition of VCAM-1 expression, effects of DAPK3 knockdown on inflammatory signals were examined. TNF (10 ng/mL, 20 minutes)-induced phosphorylation of c-Jun amino-terminal kinase (JNK; Figure 2A ), p38 ( Figure 2B ), and Akt ( Figure 2C ) was significantly inhibited by DAPK3 siRNA. To further investigate the upstream mechanisms of proinflammatory effects of DAPK3, we examined whether DAPK3 knockdown prevents TNF-induced ROS production in SMCs. TNF (10 ng/mL, 20 minutes) increased an 2′,7′-dichlorodihydrofluorescein diacetate-sensitive fluorescent intensity compared with nonstimulated control ( Figure 2D ). DAPK3 siRNA significantly inhibited the TNF-induced ROS production ( Figure 2D ). DAPK inhibitor (DI; 3 μmol/L) also inhibited TNF-induced phosphorylation of JNK, p38, and Akt in the presence of control siRNA, whereas DI had no effects in the presence of DAPK3 siRNA ( Figure S2 ), suggesting the specificity of this compound to DAPK3.
Effect of DI on TNF-α-Induced Inflammatory Responses in Human Umbilical Vein Endothelial Cells
We next examined whether DAPK3 also mediates inflammatory responses in human umbilical vein endothelial cells. , and Akt (n=5) was determined by Western blotting and shown as fold increase relative to control siRNA without TNF stimulation. Equal protein loading was confirmed using total antibody. **P<0.01 vs control siRNA without TNF; #P<0.05, ##P<0.01 vs control siRNA+TNF. Effect of DAPK3 knockdown on TNF-α-induced reactive oxygen species (ROS) production (D). ROS production was determined by a fluorescence staining using 2′,7′-dichlorodihydrofluorescein diacetate (H 2 DCFDA). After SMCs were treated with 10 ng/mL of TNF for 20 minutes in the presence of DAPK3 or control siRNA (n=6), they were loaded with H 2 DCFDA (10 μmol/L) for 30 minutes. Images were obtained using a fluorescence microscope. Scale bar, 50 μm. Fluorescent intensity was measured using Image J software and was shown as fold increase relative to control siRNA without TNF stimulation. **P<0.01 vs control siRNA without TNF; ##P<0.01 vs control siRNA+TNF.
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TNF (10 ng/mL, 24 hours)-induced expression of VCAM-1 ( Figure 3A ), endothelial-selectin (e-selectin; Figure 3B ), and cyclooxygenase (COX)-2 ( Figure 3C ), as well as monocyte adhesion to human umbilical vein endothelial cells ( Figure S3 ), were significantly inhibited by DI (3 μmol/L). DI significantly inhibited the TNF (10 ng/mL, 20 minutes)-induced ROS production ( Figure 3D ). DI alone had no effect on basal expression of the inflammatory molecules, monocyte adhesion, and ROS production ( Figures 3 and S3 ).
Effect of Long-Term DI Treatment on Blood Pressure of SHRs
We next examined the effects of long-term DI treatment (for 6 weeks) on blood pressure (BP) of SHRs (from 4 to 10 weeks old). The systolic BP, mean BP, and diastolic BP were significantly higher in SHRs than in WKYs ( Figure 4 ). DI (500 μg/kg per day) significantly decreased the BP in SHRs. Treatment of WKY with DI (500 μg/kg per day) had no influence on the BP. The heart rate was significantly higher in SHRs than in WKYs ( Figure S4 ). DI had no effect on heart rate in SHRs and WKYs.
Effect of Long-Term DI Treatment on Inflammatory Responses in Mesenteric Arteries From SHRs
To check whether DAPK3 mediates vascular inflammation in vivo, we examined the effects of long-term DI treatment on the expression of VCAM-1 and e-selectin in isolated mesenteric arteries from SHRs (10 weeks old). We confirmed that DI treatment significantly inhibited the increased DAPK3 expression in SHRs ( Figure S5 ). The expression of VCAM-1 ( Figure 5A ) and e-selectin ( Figure 5B ) significantly increased in SHRs compared with WKYs. DI (500 μg/kg per day, 6 weeks) treatment significantly normalized it. Long-term DI treatment had no influence on the expression of VCAM-1 and e-selectin in WKYs ( Figure 5A and 5B). We next examined whether long-term DI treatment attenuates ROS production. In . After HUVECs were treated with 10 ng/mL of TNF for 6 hours in the absence or presence of DI (3 μmol/L, pretreatment for 30 minutes), expression of VCAM-1 (n=3-7), e-selectin (n=3-7), and COX-2 (n=3-7) was determined by Western blotting and shown as fold increase relative to control. Equal protein loading was confirmed using total actin antibody. The same actin equal loading was used in A and C. **P<0.01 vs control; ##P<0.01 vs TNF. Effect of DI on TNF-α-induced reactive oxygen species (ROS) production (D). ROS production was determined by a fluorescence staining using 2′,7′-dichlorodihydrofluorescein diacetate (H 2 DCFDA). After HUVECs were treated with 10 ng/mL of TNF for 20 minutes in the absence or presence of DI (3 μmol/L, pretreatment for 30 minutes), they were loaded with H 2 DCFDA (10 μmol/L) for 30 minutes. Scale bar, 50 μm. Fluorescent intensity was shown as fold increase relative to control (n=3-5 Figure 5C ). DI (500 μg/kg per day, 6 weeks) treatment significantly inhibited the increased ROS production in SHRs. Long-term DI treatment had no influence on the ROS production in WKYs ( Figure 5C ).
Effect of Long-Term DI Treatment on Angiotensin II-Induced Contraction in Isolated Mesenteric Arteries From SHRs
To further explore mechanisms of the normalization of the increased BP in SHRs, we examined whether long-term DI treatment affects hypercontractility of the mesenteric artery from SHR. Angiotensin II (Ang II; 0.1-30.0 nmol/L) induced a slight contraction in mesenteric arteries from WKYs ( Figure 6A ). In mesenteric arteries from SHRs, the Ang II-induced contraction was significantly augmented. Long-term DI (500 μg/kg per day, 6 weeks) treatment reversed the augmented Ang II-induced contraction in SHRs. DI treatment had no influence on the Ang II-induced contraction in mesenteric arteries from WKYs.
Effect of Long-Term DI Treatment on AcetylcholineInduced Endothelium-Dependent Relaxation in Isolated Mesenteric Arteries From SHRs
We next examined the effects of long-term DI treatment on acetylcholine (ACh)-induced endothelium-dependent relaxation. In mesenteric arteries from WKYs (10 weeks old), ACh (0.1 nmol/L to 10 μmol/L) induced relaxation in a concentration-dependent manner ( Figure 6B ). In mesenteric arteries from SHRs, the ACh-induced relaxation was significantly impaired. Long-term DI (500 μg/kg per day, 6 weeks) treatment prevented the impaired ACh-induced relaxation in SHRs. DI treatment had no influence on the ACh-induced relaxation in WKYs.
Effect of Long-Term DI Treatment on Hypertrophy in Mesenteric Arteries From SHRs
To further explore mechanisms of the normalization of the increased BP in SHRs, we examined whether long-term DI treatment affects hypertrophy. In mesenteric arteries from SHRs, wall thickness of arterial media significantly increased compared with WKYs ( Figure 7 ). Long-term DI (500 μg/kg per day, 6 weeks) treatment inhibited the increased wall thickness in SHRs. DI treatment had no influence on the wall thickness in WKYs ( Figure 7 ).
Discussion
In the present study, we examined whether DAPK3 mediates vascular inflammatory responses and the development of hypertension. The major findings of the present study are that inhibition of DAPK3 prevents TNF-induced VCAM-1 expression and activation of JNK, p38, and Akt, as well as ROS production, in cultured vascular SMCs. It is also found that inhibition of DAPK3 prevents TNF-induced expression of 
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VCAM-1, e-selectin, and COX-2, as well as ROS production, in ECs. In the previous study, we showed that an antioxidant drug, N-acetyl l-cysteine inhibited TNF-induced expression of VCAM-1 and e-selectin, as well as activation of Akt, JNK, and p38, in cultured SMCs or endothelial cells. 14, 15 In addition, we confirmed that the inhibitor of Akt, JNK, or p38 prevented TNF-induced expression of VCAM-1 or e-selectin. Collectively, our results indicate that DAPK3 mediates TNFinduced inflammation via induction of proinflammatory molecules (VCAM-1, e-selectin, and COX-2) through activation of ROS-dependent signals in cultured SMCs and endothelial cells. It is also suggested that DAPK3 may mediate the development of hypertension in SHRs likely via ROS-dependent inflammation, hypertrophy, and hypercontractility.
DAPK3 has been implicated mainly in the regulation of cell death, including apoptosis and autophagy, in various types of cells. 8 In the recent study, we demonstrated that DAPK3 expression increases in aortas and mesenteric arteries from SHRs. 3 Nevertheless, it is unknown how DAPK3 mediates hypertensive vascular diseases via inflammation. In the present study, knockdown or inhibition of DAPK3 prevented TNF-induced inflammatory responses in vascular SMCs (Figures 1 and 2 ) and endothelial cells (Figure 3) . Although little is known about the roles of DAPK3 on inflammation, recent reports showed that DAPK family proteins modulate inflammatory responses in addition to cell death. It was reported that knockdown of DAPK1 attenuated interleukin 1β production in macrophages. 16 On the other hand, it was shown that DAPK1 and DAPK3 had negative regulatory roles in the expression of inflammatory genes, including ribosomal protein L13a, extracellular signal-regulated kinase, and interferon-γ-activated inhibitor of translation in macrophages.
12 DAPK3 has also been recognized as a novel transcriptional regulator. It was reported that leukemia . Effect of long-term death-associated protein kinase inhibitor (DI) treatment to spontaneously hypertensive rats (SHRs) on expression of vascular cell adhesion molecule (VCAM)-1 (A) and endothelial-selectin (e-selectin; B) and reactive oxygen species (ROS) production (C) in an isolated mesenteric artery. After DI was administered to SHRs (4 weeks old) or Wistar Kyoto rats (WKYs) SC at a dose of 500 μg/kg per day for 6 weeks, superior mesenteric artery was harvested. Expression of VCAM-1 (n=6; A) and e-selectin (n=6; B) was determined by Western blotting and shown as fold increase relative to WKY. Equal protein loading was confirmed using total actin antibody. After frozen sections (5 μm) of the mesenteric arteries were loaded with 2′,7′-dichlorodihydrofluorescein diacetate (H 2 DCFDA; 5 μmol/L) for 30 minutes, the fluorescence images were obtained using a fluorescence microscope. The sections treated with antioxidant, N-acetyl l-cysteine (NAC; 10 mmol/L, pretreatment for 30 minutes) or non-H 2 DCFDA-treated sections were also prepared as positive or negative control, respectively. Fluorescent intensity was shown as fold increase relative to WKY (n=4-5 
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inhibitory factor-induced phosphorylation of DAPK3 at Thr265 activated signal transducer and activator of transcription 3 signaling in HeLa cells. 17, 18 Because it was reported that signal transducer and activator of transcription 3 activity was regulated by JNK in cancer cells 19 and our data showed that DAPK knockdown inhibited the TNF-induced JNK activation, it is likely that DAPK3 mediates TNF-induced vascular inflammatory responses via the activation of transcriptional factors, including signal transducer and activator of transcription 3 through activation of JNK.
It was reported that DI inhibited activation of both DAPK1 and DAPK3 with enzyme selectivity (IC 50 =69 nmol/L for DAPK1 and 225 nmol/L for DAPK3). 20 In addition, it was shown that IP DI treatment at a concentration of 5 mg/kg improved rat cerebral ischemia. 21 Considering these reports, we used the concentration of DI (500 μg/kg per day) for in vivo study and showed that DI inhibited the increased DAPK3 expression in SHRs ( Figure S5 ). Because we confirmed that DAPK1 expression did not change in mesenteric arteries from SHRs compared with WKYs (n=4; data not shown), it is suggested that DI treatment may normalize the increased BP in SHRs mainly via the inhibition of DAPK3. In the present study, long-term DI treatment reversed the augmented Ang II-induced contraction in mesenteric arteries from SHRs (10 weeks old). It was reported previously that Ang II type 2 receptor expression increased in mesenteric arteries from young SHRs (6 weeks old), which mediated the augmented Ang II-induced contraction. 22 Therefore, it might be possible that DI reversed the augmented Ang IIinduced contraction via inhibition of Ang II type 2 receptor expression. On the other hand, it was reported that DAPK3 mediated calyculin-induced smooth muscle contraction via activation of myosin light chain kinase in aortas from SHRs. 23 In addition, it was shown that DAPK3 induced activation of regulatory myosin light chain 20 and contraction of smooth muscle. 24 These reports suggest that DAPK3 may augment Ang II-induced contraction via myosin light chain We also showed that long-term DI treatment reversed the impaired ACh-induced relaxation in mesenteric arteries from SHRs. It was previously reported that the ACh-induced relaxation in mesenteric arteries from SHRs (14 weeks old) was impaired compared with WKYs. 25 It was also reported in aortas from SHRs that endothelial NO synthase uncoupling mediated increased ROS production. 26 Therefore, we suppose that DI inhibited ROS production and, in turn, increased bioactive NO production, which led to the enhancement of ACh relaxation.
Structural change of the resistance artery is one of the important factors in the development of hypertension. It was shown that medial volume in the small muscular artery from SHRs increased compared with WKYs. 27 Another report showed that long-term treatment with sodium hydrosulfide, which possesses anti-inflammatory and antioxidant roles, decreased medial thickening and fibrosis of intramyocardial coronary arterioles via inhibition of ROS production in SHRs. 28 Activation of mitogenactivated protein kinase families (JNK, p38, and extracellular signal-regulated kinase) and Akt mediates cell proliferation of SMCs. 29 In this study, we showed that knockdown of DAPK3 inhibited TNF-induced activation of JNK, p38, and Akt in SMCs. Considering these results, we suppose that DI may inhibit hypertrophy via inhibition of cell proliferation caused by ROS-dependent activation of JNK, p38, and Akt.
Perspectives
In the present study, we for the first time demonstrated that DAPK3 promotes ROS-dependent vascular inflammation in vascular smooth muscle and endothelial cells, which may lead to the development of hypertension via propagating vascular hypercontractility and hypertrophy in SHRs. Further studies on DAPK3 might contribute to develop new pharmaceutical therapy for the prevention of hypertensive cardiovascular diseases. 
Supplemental Materials and Methods
Materials
Culture of vascular smooth muscle cells (SMCs)
Male Wistar rats (7-9-week-old) were anesthetized with urethane (1. 
Culture of human umbilical vein endothelial cells (HUVECs)
HUVECs were obtained from Kurabo (Osaka, Japan), and cultured in Medium 200
supplemented with low serum growth supplement (Cascade Biologics, Portland, OR, USA) as described previously 2 . Cells at passages from 3 to 8 were used.
Western blotting
Western blotting was performed as described previously 3 . Protein lysates were obtained by homogenizing SMCs, HUVECs or tissue samples with triton-based lysis buffer (1 % Triton X-100, 20 mM Tris, PH 7.4, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM β-glycerol phosphate, 1 mM NA 3 VO 4 , 1 µg/ml leupeptin, and 0.1 % protease inhibitor cocktail; Nacalai Tesque, Kyoto, Japan). Protein concentration was determined using the bicinchoninic acid method (Pierce, Rockford, IL, USA). Equal amount of proteins (8-10 µg) were separated by SDS-PAGE (7.5 %), and transferred to a nitrocellulose membrane (Pall, Ann Arbor, MI, USA). After being blocked with 3 % bovine serum albumin (for phosphorylation-specific antibodies) or 0. The number of attached U937 cells was randomly counted in three areas per well at x200 filed, and averaged.
Measurement of intracellular ROS production in vitro
Intracellular ROS production in SMCs or HUVECs was examined by a fluorescence staining using 2', 7'-dichlorodihydrofluorescein diacetate (H 2 DCFDA, Invitrogen Animal studies DI or vehicle (DMSO) was subcutaneously administered to male SHR (4-week-old;
Hoshino Laboratory Animals, Inc., Ibaragi, Japan) and age-matched male WKY at a dose of 500 µg/ kg/day for 6 weeks. Animal care and treatment were conducted in conformity with institutional guidelines of The Kitasato University and the National Institutes of Health Guide for the Care and
Use of Laboratory Animals. Animal study was approved by ethical committee of School of Veterinary Medicine, The Kitasato University.
Blood pressure (BP) and heart rate measurement Systolic BP (SBP), diastolic BP (DBP), mean arterial BP (MBP) and heart rate of SHR and WKY were measured using a tail-cuff system (Softron, Tokyo, Japan) in the conscious conditions 3 .
SBP and MBP were measured based on photoelectric volume and vibrational pattern of the pulse wave, respectively. The DBP was provided based on the calculations. We measured BP six times for each rat, and three stable values were averaged.
Tissue preparation SHR (0.25-0.29 kg: 10-week-old) and age-matched WKY (0.27-0.31 kg) were anesthetized with urethane (1.5 g/kg, i.p.) and euthanized by exsanguination. The superior mesenteric arteries were isolated as described previously 3 . After the fat and connective tissues were removed, the arterial samples were used for the extraction of protein, the measurement of isometric tension and the histological analysis.
Histology
After isolated mesenteric artery was embedded in OTC compound (Sakura Finetechnical Co., Ltd., Tokyo, Japan) and quickly frozen in liquid nitrogen, the thin frozen sections (5 µm) were made using a cryostat (Leica, Solms, Germany) and then stained with hematoxylin and eosin using standard protocols. The images were obtained using a light microscope (BX-51, Olympus, Tokyo, Japan). For measurement of ROS, the frozen sections were loaded with H 2 DCFDA (5 µM) for 30 min. The sections treated with anti-oxidant, NAC (10 mM, pretreatment for 30 min) or non-H 2 DCFDA-treated sections were also prepared as positive or negative control, respectively.
Fluorescence images were obtained using a fluorescence microscope. The Image J software was used for the quantitative analysis of the images.
Measurement of smooth muscle contraction
The contractility of isolated, endothelium-intact mesenteric artery was measured as described previously 4 . The arterial rings were placed in normal physiological salt solution (PSS), which contained (mM): NaCl 139.9, KCl 5.4, CaCl 2 1.5, MgCl 2 1.0, NaHCO 3 23.8, and glucose 5.5. holder under a resting tension of 0.5 g. After equilibration for 30 min in a 3 ml organ bath, each ring was repeatedly exposed to high K + solution until the responses became stable (60-90 min).
Concentration-response curves to AngII (0.1-30 nM) were obtained by the cumulative application.
The 72.4 mM KCl-induced maximal contractions were used for normalization. ACh (1 nM -300 µM) was cumulatively applied to the arteries pre-contracted to the similar level with submaximal concentrations of NA (100 nM -1 µM).
Statistical Analysis
Data are shown as means + SEM. Statistical evaluations were performed using one-way ANOVA followed by Bonferroni test. Values of P < 0.05 were considered statistically significant. Figure S1 . Effect of death associated protein kinase (DAPK)3 knockdown on TNF-α-induced DAPK3 expression. After SMCs were transfected with control or DAPK3 small interfering (siRNA), they were treated with 10 ng/ml TNF-α for 1 h. DAPK3 expression (n=4) was determined by Western blotting and shown as fold increase relative to control siRNA without TNF stimulation. Equal protein loading was confirmed using α-actin antibody. * * P<0.01 vs. control siRNA without TNF stimulation; ##P<0.01 vs. cont siRNA+TNF. Figure S4 . Effect of long-term DI treatment on heart rate of spontaneously hypertensive rats (SHR). DI was administered to SHR (4-week-old) or age-matched Wistar Kyoto rats (WKY) subcutaneously at a dose of 500 µg/ kg/day for 6 weeks (n=6). Heart rate (beat per min) was measured using a tail-cuff system at weekly intervals. Results were expressed as mean ± S.E.M. * P<0.05, * * P<0.01 vs. WKY. 
DAPK3
Total actin Figure S5 . Effect of long-term DI treatment to SHR on DAPK3 expression in an isolated mesenteric artery. After DI was administered to SHR (4-week-old) or WKY subcutaneously at a dose of 500 µg/ kg/day for 6 weeks, superior mesenteric artery was harvested. DAPK3 expression (n=3-4) was determined by Western blotting and shown as fold increase relative to WKY. Equal protein loading was confirmed using total actin antibody. * * P<0.01 vs. WKY; #P<0.05. 
